# Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age

> **NCT03314103** · PHASE3 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 30000 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **BIOLOGICAL:** One shot of the varicella-zoster virus vaccine
- **BIOLOGICAL:** one shot of placebo

## Key facts

- **NCT ID:** NCT03314103
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-06
- **Primary completion:** 2019-01-19
- **Final completion:** 2019-01-19
- **Target enrollment:** 30000 (ACTUAL)
- **Last updated:** 2021-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03314103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03314103, "Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03314103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*